Correlation Between Aquestive Therapeutics and 67401PAC2

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and 67401PAC2 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and 67401PAC2 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and OCSL 27 15 JAN 27, you can compare the effects of market volatilities on Aquestive Therapeutics and 67401PAC2 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of 67401PAC2. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and 67401PAC2.

Diversification Opportunities for Aquestive Therapeutics and 67401PAC2

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aquestive and 67401PAC2 is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and OCSL 27 15 JAN 27 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OCSL 27 15 and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with 67401PAC2. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OCSL 27 15 has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and 67401PAC2 go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and 67401PAC2

Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the 67401PAC2. In addition to that, Aquestive Therapeutics is 2.17 times more volatile than OCSL 27 15 JAN 27. It trades about -0.32 of its total potential returns per unit of risk. OCSL 27 15 JAN 27 is currently generating about -0.21 per unit of volatility. If you would invest  9,369  in OCSL 27 15 JAN 27 on September 13, 2024 and sell it today you would lose (746.00) from holding OCSL 27 15 JAN 27 or give up 7.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Aquestive Therapeutics  vs.  OCSL 27 15 JAN 27

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
OCSL 27 15 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OCSL 27 15 JAN 27 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for OCSL 27 15 JAN 27 investors.

Aquestive Therapeutics and 67401PAC2 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and 67401PAC2

The main advantage of trading using opposite Aquestive Therapeutics and 67401PAC2 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, 67401PAC2 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 67401PAC2 will offset losses from the drop in 67401PAC2's long position.
The idea behind Aquestive Therapeutics and OCSL 27 15 JAN 27 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Transaction History
View history of all your transactions and understand their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges